Tech Company Financing Transactions
Aeovian Pharmaceuticals Funding Round
Aeovian Pharmaceuticals closed a $50 million financing round on 3/29/2024. Backers included Apollo Health Ventures, b2venture and Evotec.
Transaction Overview
Company Name
Announced On
3/29/2024
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds for the completion of the Phase 1 clinical trial in healthy volunteers and prepare for the start of a subsequent Phase 2 clinical trial in adult and pediatric patients with TSC refractory epilepsy.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
We are a San Francisco Bay Area-based research stage biopharmaceutical company aiming to discover, develop and commercialize innovative therapeutics for the treatment of rare and age-related diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stelios Tzannis
Chief Financial Officer
Benjamin Zadik
VP - Regulatory Affairs
Curtis Scribner
Browse more venture capital transactions:
Prev: 3/28/2024: Soracom venture capital transaction
Next: 3/29/2024: Sense4Med venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs